Crossref
Zilebesiran – nový princíp a nová nádej v liečbe hypertenzie / Zilebesiran – a new principle and new hope in the treatment of hypertension
Cardiology Letters · 02.11.2024 · 33 (5) · 338-343
DOI: 10.4149/cardiol_2024_5_6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology Letters, online erschienen am 02.11.2024. Verfasst von Juraj Dúbrava.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dúbrava, J. (2024). Zilebesiran – nový princíp a nová nádej v liečbe hypertenzie / Zilebesiran – a new principle and new hope in the treatment of hypertension. Cardiology Letters, 33(5), 338-343. https://doi.org/10.4149/cardiol_2024_5_6
Vancouver
Dúbrava J. Zilebesiran – nový princíp a nová nádej v liečbe hypertenzie / Zilebesiran – a new principle and new hope in the treatment of hypertension. Cardiology Letters. 2024;33(5):338-343. doi:10.4149/cardiol_2024_5_6
BibTeX
@article{Dbrava2024,
author = {Dúbrava, Juraj},
title = {Zilebesiran – nový princíp a nová nádej v liečbe hypertenzie / Zilebesiran – a new principle and new hope in the treatment of hypertension},
journal = {Cardiology Letters},
year = {2024},
volume = {33},
number = {5},
pages = {338--343},
doi = {10.4149/cardiol_2024_5_6}
}
EUVIMED